$65.50
0.47% yesterday
Nasdaq, Jun 27, 10:03 pm CET
ISIN
US00182C1036
Symbol
ANIP

ANI Pharmaceuticals, Inc. Stock price

$65.50
+7.18 12.31% 1M
+11.09 20.38% 6M
+10.22 18.49% YTD
+2.41 3.82% 1Y
+35.32 117.03% 3Y
+34.30 109.94% 5Y
+4.49 7.36% 10Y
-53.30 44.87% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
-0.31 0.47%
ISIN
US00182C1036
Symbol
ANIP
Sector
Industry

Key metrics

Basic
Market capitalization
$1.4b
Enterprise Value
$1.9b
Net debt
$467.6m
Cash
$155.2m
Shares outstanding
21.7m
Valuation (TTM | estimate)
P/E
negative | 9.84
P/S
1.75 | 1.77
EV/Sales
2.32 | 2.35
EV/FCF
28.32
P/B
3.20
Financial Health
Equity Ratio
33.38%
Return on Equity
-4.70%
ROCE
2.66%
ROIC
3.61%
Debt/Equity
1.40
Financials (TTM | estimate)
Revenue
$811.5m | $801.9m
EBITDA
$119.7m | $204.7m
EBIT
$29.0m
Net Income
$-6.4m | $144.2m
Free Cash Flow
$66.6m
Growth (TTM | estimate)
Revenue
56.85% | 30.52%
EBITDA
7.05% | 190.12%
EBIT
-44.16%
Net Income
-120.91% | 815.53%
Free Cash Flow
-36.39%
Margin (TTM | estimate)
Gross
60.17%
EBITDA
14.74% | 25.53%
EBIT
3.58%
Net
-0.79% | 17.98%
Free Cash Flow
8.21%
More
EPS
$-0.32
FCF per Share
$3.07
Short interest
11.69%
Employees
897.00
Rev per Employee
$680.00k
Show more

Is ANI Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

ANI Pharmaceuticals, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a ANI Pharmaceuticals, Inc. forecast:

12x Buy
86%
2x Hold
14%

Analyst Opinions

14 Analysts have issued a ANI Pharmaceuticals, Inc. forecast:

Buy
86%
Hold
14%

Financial data from ANI Pharmaceuticals, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
812 812
57% 57%
100%
- Direct Costs 323 323
68% 68%
40%
488 488
50% 50%
60%
- Selling and Administrative Expenses 326 326
88% 88%
40%
- Research and Development Expense 55 55
42% 42%
7%
120 120
7% 7%
15%
- Depreciation and Amortization 91 91
52% 52%
11%
EBIT (Operating Income) EBIT 29 29
44% 44%
4%
Net Profit -6.44 -6.44
121% 121%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about ANI Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ANI Pharmaceuticals, Inc. Stock News

Neutral
GlobeNewsWire
16 days ago
The Use of Purified Cortrophin® Gel in Murine Collagen-Induced Arthritis Mouse Model presented as a poster at the European Alliance of Associations for Rheumatology (EULAR) 2025 Congress The Use of Purified Cortrophin® Gel in Murine Collagen-Induced Arthritis Mouse Model presented as a poster at the European Alliance of Associations for Rheumatology (EULAR) 2025 Congress
Neutral
GlobeNewsWire
about one month ago
PRINCETON, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City as follows:
Neutral
GlobeNewsWire
about one month ago
Purified Cortrophin Gel is the only ACTH therapy approved by the FDA for the treatment of  acute gout flares Trial to be conducted by Dr. Hyon Choi at Massachusetts General Hospital and will compare the safety and efficacy of two dose levels of Purified Cortrophin Gel for the treatment of acute gout flares PRINCETON, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the C...
More ANI Pharmaceuticals, Inc. News

Company Profile

ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

Head office United States
CEO Nikhil Lalwani
Employees 897
Founded 1996
Website www.anipharmaceuticals.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today